Return
Biography
Vlachaki

Dr. Vlachaki Efthymia

Thalassemia Unit, Hippokrateon General Hospital

School of Medicine, Aristotle University, Greece


E-mail: efivlachaki@yahoo.gr


Qualifications

2003 Ph.D., “Effect of cytokines combination on Umbilical cord blood CD34+cells in liquid Cultures”
1989-1996  Hematology Specialization
1982-1988 M.D., Medical Education Medical Diploma (Ptychio Iatrikes) Aristotle University of Thessaloniki, Greece


Publications(Selected)

  1. Sarigianni M, Liakos A, Vlachaki E, Paschos P, Athanasiadou E, Montori VM, Murad MH, Tsapas A, Accuracy of Magnetic Resonance Imaging in Diagnosis of Liver Iron Overload: a Systematic Review and Meta-analysis. (2014) Clin Gastroenterol Hepatol. 2014 Jun 30. pii: S1542-3565(14)00928-8. doi: 10.1016/j.cgh.2014.05.027.
  2. Psarras K, Symeonidis N, Vlachaki E, Baltatzis M, Papatolios G, Pavlidis E, Mouratidou C, Venizelos I, Pavlidis T, Sakantamis A, Nikolaidou C, Primary gallbladder small lymphocytic lymphoma as a rare postcholecystectomy finding. (2014) Case Rep Hematol.2014:716071.
  3. Triantafyllou P, Economou M, Vlachaki E, Aggelaki M, Athanassiou-Mataxa M, Michelakaki E, Zafeiriou D I, Multiple endocrine disorders associated with adrenomyeloneuropathy and a novel mutation of the ABCD1 gene. (2014) Pediatr Neurol 50(6):622-4.
  4. Vlachaki E, Andreadis P, Neokleous N, Agapidou A, Vetsiou E, Katsinelos P, Boura P, Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/ β (+) Thalassemia, (2014) Case Rep Hematol 2014:213631.
  5. Theodoridou S, Economou M, Vyzantiadis TA, Teli A, Vlachaki E, Neokleous N, Kargioti A, Vakalopoulou S, Garypidou V, Gombakis N, Papachristou F, Laboratory investigation of platelet function in patients with thalassaemia. (2014) Acta Haematol 132(1):45-8.
  6. Hatzipantelis ES, Karasmanis K, Perifanis V, Vlachaki E, Tziomalos K, Economou  M, Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients. (2014) Hemoglobin 38(2):111-4.
  7. Efthimia Vlachaki, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, Perifanis V, Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience. (2013) Ann Hematol 92(2):263-5.
  8. Agapidou A, Vlachaki E, Theodoridis T, Economou M, Perifanis V, Cyclosporine therapy during pregnancy in a patient with β-thalassemia major and autoimmune haemolytic anemia: a case report and review of the literature. (2013) Hippokratia 17(1):85-7
  9. Vlachaki E, Mainou M, Bekiari E, Vetsiou E, Tsapas A, Safety and efficacy of 4 years of deferasirox treatment for sickle cell disease patients. (2013) Hemoglobin 37(1):94-100
  10. Vlachaki, E., Diamantidis, M.D., Klonizakis, P., Haralambidou-Vranitsa, S., Ioannidou-Papagiannaki, E., Klonizakis, I, Pure red cell aplasia and lymphoproliferative disorders: An infrequent association, (2012) The Scientific World Journal, 2012, art. no. 475313.
  11. Sinakos, E., Vlachaki, E., Tsapas, A, Safety of deferasirox in sickle cell disease patients with co-existing liver impairment, (2012) British Journal of Haematology, 157 (4), pp. 505-506.
  12. Bourli, E., Dimitriadou, M., Economou, M., Vlachaki, E., Christoforidis, A., Maratou, E., Stanopoulos, I., Aivazis, V, Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major, (2012) Pediatric Pulmonology 2012 Aug;47(8):801-7
  13. Vlachaki, E., Kalogeridis, A., Neokleous, N., Perifanis, V., Klonizakis, F., Ioannidou, E., Klonizakis, I, Absence of JAK2V617F mutation in patients with beta-thalassemia major and thrombocytosis due to splenectomy, (2011) Molecular Biology Reports, pp. 1-5.
  14. Sarigianni M, Vlachaki E, Chissan S, Klonizakis F, Vetsiou E, Anastasiadou KI, Ioannidou-Papagiannaki E, Klonizakis I, Haematoma caused by bone marrow aspiration and trephine biopsy. (2011) Hematol Rep 3(3):e25.  Cited 8
  15. Vlachaki E, Papageorgiou V, Klonizakis F, Spandonidou M, Chisan S, Vetsiou E, Ioannidou E. Total remission of severe immune thrombocytopenia after short term treatment with romiplostim. (2011) Hematol Rep. 3(3):e20.